Patents by Inventor Robert D. Larsen

Robert D. Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5693816
    Abstract: The present invention relates to an improved process for the in situ preparation of diisopinocampheylchloroborane which comprises reacting sodium borohydride and boron trichloride with .alpha.-pinene. The diisopinocampheylchloroborane thus obtained may be used, without isolation, to reduce prochiral ketones to their corresponding alcohols in high optical purity.
    Type: Grant
    Filed: January 16, 1996
    Date of Patent: December 2, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Anthony On-Ping King, Robert D. Larsen, Thomas R. Verhoeven, Mangzhu Zhao
  • Patent number: 5567824
    Abstract: A new process is described for the synthesis of the triazolyl tryptamine: ##STR1## and related compounds. The process involves a palladium-catalyzed ring closure between a substituted ortho-iodoaniline and a protected 1-alkynol. The process is carded out at high temperature, e.g. 100.degree. C., in a dry inert solvent, e.g., DMF and in the presence of a proton acceptor, e.g., Na.sub.2 CO.sub.3 or a trialkylamine. The triazolyl tryptamine, as well as acid addition salts thereof, is a 5 HT.sub.1 D receptor agonist having anti-migraine properties.
    Type: Grant
    Filed: May 24, 1994
    Date of Patent: October 22, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Cheng Y. Chen, Robert D. Larsen, Thomas R. Verhoeven
  • Patent number: 5545758
    Abstract: The present invention relates to an improved process for the in situ preparation of diisopinocampheylchloroborane which comprises reacting sodium borohydride and boron trichloride with .alpha.-pinene. The diisopinocampheylchloroborane thus obtained may be used, without isolation, to reduce prochiral ketones to their corresponding alcohols in high optical purity.
    Type: Grant
    Filed: August 11, 1994
    Date of Patent: August 13, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Anthony O. King, Robert D. Larsen, Thomas R. Verhoeven, Mangzhu Zhao
  • Patent number: 5424432
    Abstract: This invention relates to a method for the preparation of a compound of formula I: ##STR1## a key intermediate in the synthesis of a series of Angiotensin II receptor antagonists. The invention also relates to a selective reagent for conducting the Hofmann rearrangement, particularly in the formation of a pyridinoimidazolone, which is a percursor to the formation of an imidazopyfidine of formula I. This invention also relates to a method for the preparation of imidazolutidine, a key intermediate in the synthesis of 3-(2'-(N-benzoyl)sulfonamidobiphen-4-yl)-methyl-5,7 -dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine, using pyridinoimidazolone, an unreactive urea.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: June 13, 1995
    Assignee: Merck & Co., Inc.
    Inventors: Laura E. Fredenburgh, Robert D. Larsen, Ji Liu, Robert A. Reamer, Chris H. Senanayake, Thomas R. Verhoeven
  • Patent number: 5310928
    Abstract: Method for the preparing biphenyltetrazole compounds which are angiotensin II receptor antagonists or which are useful intermediates to prepare angiotensin II receptor antagonists. An illustrative biphenyl tetrazole compound is 2-n-butyl-4-chloro-1-[(2'-(tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-1H-im idazole-5-methanol, potassium salt.
    Type: Grant
    Filed: July 10, 1992
    Date of Patent: May 10, 1994
    Assignees: E. I. Du Pont de Nemours and Company, Merck & Co., Inc.
    Inventors: Young S. Lo, Lucius T. Rossano, Robert D. Larsen, Anthony O. King
  • Patent number: 5241083
    Abstract: The natural stereochemistry at the 13-position of avermectin aglycones, normally .alpha.-oriented or below the plane of the molecule, is inverted or epimerized into the .beta.-position. The procedure starts with the avermectin aglycone compounds where the 13.alpha.-hydroxy group is activated to a mesylate leaving group. The resultant 13-.alpha.-mesylate is then displaced with a cesium carboxylate and one equivalent of the respective carboxylic acid, ending with the ester group being converted to the 13-.beta.-hydroxy configuration by transesterification in high yield.
    Type: Grant
    Filed: July 1, 1992
    Date of Patent: August 31, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Timothy Bill, Chris H. Senanayake, Robert D. Larsen, Sheo B. Singh, Thomas R. Vernhoeven
  • Patent number: 4946997
    Abstract: A process is described for the racemization of an optically active carboxylic acid of structure (I): ##STR1## which comprises the treatment of (I) with an acid anhydride and its conjugate base.
    Type: Grant
    Filed: June 7, 1989
    Date of Patent: August 7, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Robert D. Larsen, Paul Reider
  • Patent number: 4940813
    Abstract: A process is described for the preparation of an optically active carboxylic acid or ester derivative thereof from a ketene and an optically active .alpha.-hydroxyester or an .alpha.-hydroxy amide.
    Type: Grant
    Filed: March 31, 1989
    Date of Patent: July 10, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Edward G. Corley, Robert D. Larsen, Edward J. J. Grabowski, Paul Reider
  • Patent number: 4758661
    Abstract: (+)-trans-1a,2,3,4a,5,6-Hexahydro-9-hydroxy-4-propyl-4H-naphth[1,2-b]-1,4-o xazine is elaborated by a series of process steps that retain the enantiomeric purity of the starting material, D-aspartic acid. The product is a direct acting dopaminergic agent, useful in the treatment of Parkinson's disease.
    Type: Grant
    Filed: June 24, 1986
    Date of Patent: July 19, 1988
    Assignee: Merck & Co., Inc.
    Inventors: David G. Melillo, David J. Mathre, Robert D. Larsen
  • Patent number: 4111245
    Abstract: An apparatus for delimbing felled trees is described, wherein the trees are pulled individually or, in some cases, in bundles through the delimber. The delimber is provided with a base; a lower impact shear blade which is a notched steel plate supported upon the base, the notch bounding the under half circumference of a tree in the delimber; upper impact shear blades which are a pair of arcuate arms pivoted on the base, designed and arranged such that a tree resting in the notched plate is bound substantially about its upper half circumference by the arcuate arms pivoted into contact with the tree; and an activating plate, pivoted upon the base, interconnected with the arcuate arms such that the weight and force of a tree pulled through the delimber in contact with the notched plate, acts upon the activating plate causing it to pivot thereby pulling the arms into contact with the tree.
    Type: Grant
    Filed: December 23, 1976
    Date of Patent: September 5, 1978
    Assignee: Weyerhaeuser Company
    Inventors: Carl M. McCrary, Robert D. Larsen